On 29.01.2019 A-Sense Sp z o.o. signed with the Polish Agency for Enterprise Development an Agreement for co-financing the project under sub-measure 2.3.2 Vouchers for innovations for SMEs of the Intelligent Development Operational Program, 2014-2020.
Project title: "Innovative technology for the production of asymmetric synthesis of (S) nicotine".
Project objective: The subject of the project is a research service consisting in the development of an innovative technology for the production of asymmetric synthesis of (S) nicotine. The scope of the project will include:
- Development of the concept of the technology of asymmetric synthesis of (S) Nicotine;
- Development of the method of asymmetric synthesis of (S) Nicotine on the 10 g scale (synthesis and separation of racemic and enriched nicotine),
- Development of the method of synthesis of (S) Nicotine on the 200g scale . (Including enantiomer recycling), - Analytical research, preparation of documentation and reports,
- Involving recipients in the design process, creating / participating in opinions and testing.
On 31.07.2019. A-Sense Sp z o.o. signed an Agreement with the Lublin Agency for Entrepreneurship Support for financing the project under Measure 3.7 of the ROP LV 2014-2020.
Project title: "Increase of the competitiveness of A-sense Sp. Z o.o. by implementing R&D works in an innovative technology for the production of synthetic cannabidiol ”.
Project objective: The main assumption of the works is to increase the competitiveness of A-sense Sp. z o. o. on the domestic and foreign market, and increasing the productivity and efficiency of enterprises by implementing the results of research and development in the field of developing an innovative method of obtaining synthetic cannabidiol. Research and development works in the field of developing an innovative tech. the production of synthetic cannabidiol was carried out by the Applicant and scientists at the request of the Applicant. The applicant has full rights to the results of R&D works. The result of the project will be the expansion of the company's offer with synthetic cannabidiol, showing significant advantages over naturally obtained cannabidiol.